Insulet (PODD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $142.28 -3.53%
Revenue Growth %: +18.1%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q1 EPS of ($0.19), inline with the analyst estimate. Revenue for the quarter came in at $81.2 million versus the consensus estimate of $79.06 million.
GUIDANCE:
Insulet sees Q2 2016 revenue of $81-84 million, versus the consensus of $82.3 million.
- For the year ending December 31, 2016, the Company is reaffirming its revenue guidance of $330 to $350 million
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Chime to acquire Stride Bank for $590M in cash
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
